5 Biggest Immunotherapy Companies in the World

4. Roche Holding AG (ROG.SW)

Market Capitalization: $255.13 billion (CHF227.37 billion)

Number of Hedge Fund Holders: N/A

Roche Holding AG (ROG.SW) is a Basel, Switzerland-based global healthcare company involved in oncology, immunology, and other areas of medical research. Roche Holding AG (ROG.SW) has expanded its efforts to combat KRAS-mutated cancer by securing the rights to Hookipa Pharma’s HB-700 and an option for another arenaviral immunotherapy. In exchange, Roche Holding AG (ROG.SW) is making an upfront payment of $25 million and pledging up to $930 million in potential payments. Roche Holding AG (ROG.SW) offers an annual forward dividend yield of 3.38% as of April 28.